Cancer Imaging in ‘The Dartmouth’

Researchers from Dartmouth-Hitchcock Medical Center and the Thayer School of Engineering have developed a quantitative imaging system to detect low-grade brain cancer cells and make tumor removal more precise, according to Thayer School professor and research group co-leader Keith Paulsen.

The technology consists of a drug, taken pre-operatively, which is broken down, processed and moved into brain tumor tissue.

The fluorescent compound accumulates most intensely in high-grade brain tumor cells, which are not curable by surgery, according to Paulsen. Low-grade tumor cells that are potentially curable, however, accumulate a lower percentage of the compound.

To learn more about this collaborative research project, read Elizabeth Mc Nally’s article in The Dartmouth